FolioMetrix’s Incyte INCY Stock Holding History

FolioMetrix’s Portfolio INCY Stock Details INCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-4,527	Closed	-$288K	–	245
2014 Q4	$288K	Buy	+4,527	New	+$296K	0.2%	103

Other funds holding INCY

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FolioMetrix's INCY Position: Q1 2015 in Review

FolioMetrix sold out of Incyte (INCY) in Q1 2015, closing a stake of 4,527 shares — an estimated $288K sold.

FolioMetrix first reported a position in INCY in Q4 2014 and held it in 1 quarter. The position peaked at $288K in Q4 2014. 304 funds tracked by Wall St. Rank hold INCY as of Q1 2015.

FolioMetrix reported no remaining Incyte position as of Q1 2015 after selling out during the quarter.
FolioMetrix sold 4,527 Incyte shares in Q1 2015, an estimated $288K.
FolioMetrix first reported a position in Incyte in Q4 2014 and held it in 1 quarter.
FolioMetrix's Incyte position peaked at $288K in Q4 2014.
304 funds tracked by Wall St. Rank held Incyte as of Q1 2015.

Based on FolioMetrix's 13F filing for Q1 2015, filed 28 Apr 2015.